Collection of telemedical data from patients with chronic heart failure for a post-hoc analysis of an AI approach to vital signs processing (short title: Telemed5000-HF) - Telemed5000-HF

Charité- Campus Charité Mitte0 个研究点目标入组 100 人开始时间: 2023年5月3日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. patients with chronic heart failure in NYHA class II or III.
•2. echocardiographically determined left ventricular ejection fraction (LVEF) =45% or LVEF >45% + at least 1 diuretic in long-term medical therapy.
•3. have been hospitalised for cardiac decompensation<12 months prior to inclusion in the study (not related to a proven myocardial infarction without pre-existing moderately restricted LVEF) (doctor's letter available).
•4. no moderate or severe depression
•5. written informed consent of the patient

•1. hospitalisation within the last 7 days before study start (exept due to cardiac decompensation)
•2. condition after implantation of a mechanical cardiac assist system
•3. acute coronary syndrome within the last 7 days before study inclusion
•4. high urgent HTX listing
•5. planned revascularisation, TAVI, mitraclip and/or CRT implantation within 3 months of study inclusion
•6. revascularisation and/or CRT implantation within 3 months prior to study inclusion
•7. chronic drug or alcohol abuse as assessed by the physician
•8. terminal renal failure with haemodialysis treatment
•9. inability or unwillingness to perform telemonitoring (e.g. dementia, blindness, deafness, wheelchair use, insufficient knowledge of German, speech or voice disorders affecting voice analysis, limited informal self-determination)
•10. illnesses with a life expectancy<12 months
•11. age<18 years
•12. pregnancy
•13. participation in therapy studies (observational studies and registers are possible)

发起方

Charité- Campus Charité Mitte